Clinical Outcome And Toxicity Of Induction Followed By Definitive Concurrent Chemoradiotherapy With Weekly Paclitaxel Plus Carboplatin In Squamous Cell Carcinoma Of Esophagus Unsuitable For Surgery

被引：0
|
作者：
Rastogi, M. [1 ]
Gandhi, A. K. [1 ]
Singh, H. B. [1 ]
Nanda, S. S., Sr. [2 ]
Rath, S. [1 ]
Khurana, R. [1 ]
Hadi, R. [3 ]
Mishra, S. P. [1 ]
Srivastva, A. K. [3 ]
Bharati, A. [1 ]
机构：
[1] Dr Ram Manohar Lohia Inst Med Sci, Dept Radiat Oncol, Lucknow, Uttar Pradesh, India
[2] TMH, Varanasi, Uttar Pradesh, India
[3] Dr Ram Manohar Lohia Inst Med Sci, Lucknow, Uttar Pradesh, India
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3535
引用
收藏
页码：E662 / E663
页数：2
相关论文
共 50 条
  • [21] Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma
    Barone, C.
    Grillo, R.
    Dongiovanni, D.
    Birocco, N.
    Rampino, M.
    Redda, M. G. Ruo
    Garibaldi, E.
    Munoz, F.
    Pecorari, G.
    Cavalot, A.
    Garzinodemo, P.
    Buffoni, L.
    Ciuffreda, L.
    Ricardi, U.
    Cortesina, G.
    Giordano, C.
    Fasolis, M.
    Berrone, S.
    Bertetto, O.
    Schena, M.
    ANTICANCER RESEARCH, 2008, 28 (2B) : 1285 - 1291
  • [22] Comparative Outcomes of Induction Chemotherapy Followed By Definitive Chemoradiotherapy versus Chemoradiotherapy Alone In Esophageal Squamous Cell Carcinoma
    Luo, Li-Ling
    Xi, Mian
    Yang, Ya-Di
    Li, Qiao-Qiao
    Zhao, Lei
    Zhang, Peng
    Liu, Shi-Liang
    Liu, Meng-Zhong
    JOURNAL OF CANCER, 2017, 8 (17): : 3441 - 3447
  • [23] Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5-fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real-world evidence
    Hsieh, Jason Chia-Hsun
    Chiang, Pin-Chun
    Hung, Tsung-Min
    Chao, Yin-Kai
    Kuo, Yung-Chia
    Wen, Chih-Tsung
    Su, Po-Jung
    Peng, Meng-Ting
    Chen, Huan-Wu
    Liu, Hui-Ling
    Chang, Hsien-Kun
    Wu, Min-Hsien
    Wang, Hung-Ming
    CANCER MEDICINE, 2021, 10 (23): : 8300 - 8309
  • [24] Induction Chemotherapy with Docetaxel, Cisplatin and Fluorouracil Followed by Surgery and Concurrent Chemoradiotherapy Improves Outcome of Recurrent Advanced Head and Neck Squamous Cell Carcinoma
    Yang, Wen-Chi
    Chen, Chung-Ho
    Tang, Jen-Yang
    Wu, Chih-Fung
    Liu, Yi-Chang
    Sun, Youping
    Lin, Sheng-Fung
    ANTICANCER RESEARCH, 2014, 34 (07) : 3765 - 3773
  • [25] Induction chemotherapy with paclitaxel, carboplatin, and cetuximab (PCE) followed by chemoradiotherapy for unresectable locoregional recurrence after curative surgery in patients with squamous cell carcinoma of the head and neck
    Sato, Masanobu
    Enokida, Tomohiro
    Fujisawa, Takao
    Okano, Susumu
    Takeshita, Naohiro
    Tanaka, Nobukazu
    Tanaka, Hideki
    Motegi, Atsushi
    Zenda, Sadamoto
    Shinozaki, Takeshi
    Matsuura, Kazuto
    Hayashi, Ryuichi
    Akimoto, Tetsuo
    Tahara, Makoto
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [26] The role of surgery or definitive chemoradiotherapy in management of localized squamous cell carcinoma of esophagus - What is the verdict?
    Hngorani, Mohan
    Jain, Prashant
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 190
  • [27] Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma
    Barbetta, Arianna
    Hsu, Meier
    Tan, Kay See
    Stefanova, Dessislava
    Herman, Koby
    Adusumilli, Prasad S.
    Bains, Manjit S.
    Bott, Matthew J.
    Isbell, James M.
    Janjigian, Yelena Y.
    Ku, Geoffrey Y.
    Park, Bernard J.
    Wu, Abraham J.
    Jones, David R.
    Molena, Daniela
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (06): : 2710 - 2719
  • [28] A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis
    Li, Yang
    Du, Qingwu
    Wei, Xiaoying
    Guo, Zhoubo
    Lei, Tongda
    Li, Yanqi
    Han, Dong
    Wu, Xiaoyue
    Zhang, Kunning
    Zhang, Tian
    Chen, Xi
    Dong, Jie
    Zhang, Baozhong
    Wei, Hui
    Zhang, Wencheng
    Pang, Qingsong
    Wang, Ping
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [29] Induction chemotherapy and concurrent chemoradiotherapy with cisplatin for T4 nasoethmoidal squamous cell carcinoma: The value of paclitaxel, carboplatin and cetuximab (PCE)
    Tanaka, Nobukazu
    Enokida, Tomohiro
    Okano, Susumu
    Fujisawa, Takao
    Tanaka, Hideki
    Onaga, Ryutaro
    Hoshi, Yuta
    Kishida, Takuma
    Wada, Akihisa
    Sato, Masanobu
    Takeshita, Naohiro
    Fujisawa, Takeshi
    Motegi, Atsushi
    Zenda, Sadamoto
    Akimoto, Tetsuo
    Tahara, Makoto
    ORAL ONCOLOGY, 2025, 163
  • [30] Induction chemotherapy (CT) with weekly paclitaxel, carboplatin, and cetuximab for squamous cell carcinoma of the head and neck (HN).
    Kies, M. S.
    Garden, A. S.
    Holsinger, C.
    Papadimitrakopoulou, V.
    El-Naggar, A. K.
    Gillaspy, K.
    Lewin, J.
    Lu, C.
    Villalobos, S.
    Glisson, B. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 285S - 285S
12345